See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Namenda, Ebixa, Alzant
What is Memantine?
Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. It is also being tested for use as a cognitive enhancer in a variety of other conditions.
Read more...
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my ALS progress | 15 | 22% |
| Other | 12 | 17% |
| Memory problems | 5 | 7% |
| Brain fog | 4 | 5% |
| Emotional lability | 2 | 2% |
| Pain | 2 | 2% |
| Cognition | 2 | 2% |
| Stiffness/Spasticity | 2 | 2% |
| Treat my PSP | 2 | 2% |
| Migraine | 1 | 1% |
| Memory Loss | 1 | 1% |
| occipital neuralgia | 1 | 1% |
| Dementia | 1 | 1% |
| Vision | 1 | 1% |
| visual migraine | 1 | 1% |
| brain fog, cognition, and s/t memory loss | 1 | 1% |
| don't know | 1 | 1% |
| Short term memory problems | 1 | 1% |
| Loss of short term memory | 1 | 1% |
Other treatments patients are taking for Slow my ALS progress include Riluzole, CoQ10 Coenzyme Q10, and Lithium Carbonate.
Based on the patients currently taking Memantine.
How long current patients have been taking Memantine or how long patients were taking Memantine before stopping.
Results from 10 patient evaluations. See the overall results and all individual evaluations.
| Major | 100% | 2 |
|---|
Other
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 10% | 1 |
| Mild | 10% | 1 |
| None | 80% | 8 |
Top reported side-effects include: Vivid dreams, Metallic taste in mouth
Summary results are based on 10 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Report created on November 08, 2009.